NAN, D. et al. Delayed Use of the Recombinant Human IL-1 Receptor Antagonist Anakinra in Five COVID-19 Patients with Pulmonary Fibrosis and Persistent Hypoxaemia: A Preliminary Report. European Journal of Case Reports in Internal Medicine, v. 8, n. 10, 8 Oct.2021.